MedPath

Nasal interfaces for CPAP- what is best for the preterm infant?

Completed
Conditions
Preterm infants between 26-32 weeks gestation requiring continuous positive airway pressure
Registration Number
CTRI/2012/08/002868
Lead Sponsor
All India Institute of medical sciences
Brief Summary

This study is a randomized, open label parallel group single centre study comparing the efficacy and safety of CPAP delivery through nasal masks versus bi-nasal prongs in preterm babies with respiratory distress syndrome. The efficacy will be measured as the area under the curve of FiO2 requirement against time during the first 72 hours of CPAP application and safety will be measured by the incidence of nasal trauma and air leaks in both groups.

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
72
Inclusion Criteria

Preterm babies of 26+0 – 32+6 weeks of gestation Respiratory distress requiring CPAP within 6 hours of life Informed parental consent.

Exclusion Criteria

Major congenital malformations Any known anomaly known to interfere with delivery of CPAP such as congenital diaphragmatic hernia, trachea oesophageal fistula, choanal atresia, cleft palate and nasal deformities, severe cardiovascular instability.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Area under the curve of FiO2 against time during the first 72 hours of CPAP application1. Area under the curve of FiO2 against time during the first 72 hours of CPAP application | 2. Mean FiO2 requirement at 24 , 48 and 72 hours of CPAP
2. Mean FiO2 requirement at 24 , 48 and 72 hours of CPAP1. Area under the curve of FiO2 against time during the first 72 hours of CPAP application | 2. Mean FiO2 requirement at 24 , 48 and 72 hours of CPAP
Secondary Outcome Measures
NameTimeMethod
1.Proportion of babies requiring intubation in the first 72 hours of life2.Proportion of babies who develop nasal trauma

Trial Locations

Locations (1)

Neonatal Intensive care unit- A (Dept of pediatrics), C3 ward, AIIMS

🇮🇳

Delhi, DELHI, India

Neonatal Intensive care unit- A (Dept of pediatrics), C3 ward, AIIMS
🇮🇳Delhi, DELHI, India
Dr Aparna Chandrasekaran
Principal investigator
9013860039
appubanu@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.